Scinai Immunotherapeutics offering covers 7.6 million ADS representing 303.50 billion ordinary shares, SEC filing says
SCNI•A SEC filing says an offering by selling shareholders relates to 7.6 million Scinai Immunotherapeutics ADS representing 303.50 billion ordinary shares.
1. Offering details
The offering by selling shareholders relates to 7.6 million Scinai Immunotherapeutics ADS representing 303.50 billion ordinary shares, according to an SEC filing.
